Becton Dickinson & Company

BDX NYSE Healthcare & Biotech Monde US0758871091
143.34 $
1.04 %

Becton Dickinson & Company is a global medical technology company specializing in the manufacturing of medical devices, diagnostic products, and reagents.

Price history of Becton Dickinson & Company
Price history of Becton Dickinson & Company

Performance & Momentum

6 Months 2.41 %
1 Year 6.42 %
3 Years 23.29 %
5 Years 16.14 %

Strategic Analysis

Becton Dickinson & Company • 2026

Becton Dickinson & Company occupies an essential global supplier position in medical devices, diagnostics, and reagents, with a diversified portfolio at the heart of healthcare delivery. Its business model is built on recurring usage, a strong hospital footprint, and high barriers to entry tied to regulation, industrial quality, and long-term relationships with healthcare institutions.

Strengths
  • Exposure to structural, non-discretionary healthcare needs, supporting relatively resilient demand
  • Diversified portfolio across devices, diagnostics, and consumables, reducing dependence on a single product line
  • International positioning with an established presence among hospitals and laboratories, which supports recurring business
Weaknesses
  • Growth is often steadier than spectacular, limiting the potential for a rapid rerating
  • Potential sensitivity to margin pressure in medical devices and to capital spending cycles at healthcare institutions
Momentum

Momentum appears moderately positive, with a recent rebound that contrasts with a weaker trajectory over intermediate and longer periods. The stock seems to be in a cautious recovery phase rather than in a clearly sustained uptrend, making it a quality defensive name to watch rather than a strong acceleration story.

Similar stocks to Becton Dickinson & Company

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone